Cover Image
市場調查報告書

全球動物用疫苗市場展望

Global Animal Vaccines Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 311854
出版日期 內容資訊 英文 89 Pages
訂單完成後即時交付
價格
Back to Top
全球動物用疫苗市場展望 Global Animal Vaccines Market 2014-2018
出版日期: 2014年09月03日 內容資訊: 英文 89 Pages
簡介

全球動物用疫苗市場,預計從2013年到2018年以8.25%的CAGR成長。

本報告提供全球動物用疫苗市場現況與展望的相關調查、各對象動物與地區的市場成長預測、市場影響因素與市場上課題等分析、競爭環境與市場佔有率、主要企業及關注的企業簡介等彙整資料。

第1章 摘要整理

第2章 簡稱

第3章 分析範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查的流程
  • 調查手法

第5章 簡介

第6章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各產品市場區隔

  • 全球家畜用疫苗市場
    • 市場規模與預測
  • 全球寵物用疫苗市場
    • 市場規模與預測
  • 全球豬用疫苗市場
    • 市場規模與預測
  • 全球雞用疫苗市場
    • 市場規模與預測
  • 全球馬用疫苗市場
    • 市場規模與預測
  • 全球及其他的動物用疫苗市場
    • 市場規模與預測

第8章 各技術市場

第9章 各地區市場

  • 南北美洲
    • 市場規模與預測
  • 歐洲、中東、非洲
    • 市場規模與預測
  • 亞太地區
    • 市場規模與預測

第10章 購買標準

第11章 市場促進因素

第12章 成長推進因素與其影響

第13章 市場課題

第14章 成長推進因素與課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 供應商環境

  • 競爭模式
  • 市場佔有率分析
  • 其他突出的供應商
  • Bayer Healthcare
  • Elanco Animal Health
  • Merck Animal Health
  • Novartis Animal Health
  • Sanofi
  • Zoetis
    • 主要資料
    • 產業概要
    • 各產業分類收益
    • 產業策略
    • 主要的發展趨勢
    • SWOT分析等

圖表

目錄
Product Code: IRTNTR4047

About Animal Vaccines

Animal vaccines are biological preparations used to improve the immunity of animals. Animal vaccines are generally prepared from weakened or dead microbes that can cause a particular disease when in their healthy state. Some of the animal vaccines are also formulated using a part of a microbe's body such as protein subunits or toxic components. These components act as stimulating agents that trigger the immune system in an animal body. This then prepares the necessary antibodies to act against the microbes present in the body or to destroy any that it encounters in the future. Based on their applications, animal vaccines are predominantly categorized into livestock vaccines, companion vaccines, and aquaculture vaccines.

TechNavio's analysts forecast the Global Animal Vaccines market to grow at a CAGR of 8.25 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Animal Vaccines market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various animal vaccines. In terms of vaccines types, the Global Animal Vaccines market can be segmented into six: Companion Animal Vaccines, Livestock Vaccines, Porcine Vaccines, Poultry Vaccines, Equine Vaccines, and Other Animal Vaccines.

TechNavio's report, the Global Animal Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Animal Vaccines market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Bayer HealthCare
  • Elanco Animal Health
  • Merck Animal Health
  • Novartis Animal Health
  • Sanofi
  • Zoetis

Other Prominent Vendors

  • BioCell
  • Biogenesis Bago
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Heska
  • Imugene
  • Indian Immunologicals
  • Lohmann Animal Health International
  • Virbac

Market Driver

  • Growing Prevalence of Animal Diseases

For a full, detailed list, view our report

Market Challenge

  • Increase in Vaccine Maintenance Costs

For a full, detailed list, view our report

Market Trend

  • Increase in Acquisitions

For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Products

  • 07.1. Global Livestock Vaccines Market
    • 07.1.1. Market Size and Forecast
  • 07.2. Global Companion Animal Vaccines Market
    • 07.2.1. Market Size and Forecast
  • 07.3. Global Porcine Vaccines Market
    • 07.3.1. Market Size and Forecast
  • 07.4. Global Poultry Vaccines Market
    • 07.4.1. Market Size and Forecast
  • 07.5. Global Equine Vaccines Market
    • 07.5.1. Market Size and Forecast
  • 07.6. Global Other Animals Vaccines Market
    • 07.6.1. Market Size and Forecast

08. Market Segmentation by Technology

09. Geographical Segmentation

  • 09.1. Animal Vaccines Market in Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. Animal Vaccines Market in the EMEA Region
    • 09.2.1. Market Size and Forecast
  • 09.3. Animal Vaccines Market in the APAC Region
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2013
  • 17.3. Other Prominent Vendors
  • 17.4. Bayer Healthcare
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Business Segmentation by Revenue 2013
    • 17.4.4. Business Segmentation by Revenue 2012 and 2013
    • 17.4.5. Geographical Segmentation by Revenue 2013
    • 17.4.6. Business Strategy
    • 17.4.7. Recent Developments
    • 17.4.8. SWOT Analysis
    • 17.4.9. Strengths
    • 17.4.10. Weaknesses
    • 17.4.11. Opportunities
    • 17.4.12. Threats
  • 17.5. Elanco Animal Health
    • 17.5.1. Key Facts
    • 17.5.2. Business Overview
    • 17.5.3. Business Strategy
    • 17.5.4. Recent Developments
    • 17.5.5. SWOT Analysis
    • 17.5.6. Strengths
    • 17.5.7. Weaknesses
    • 17.5.8. Opportunities
    • 17.5.9. Threats
  • 17.6. Merck Animal Health
    • 17.6.1. Key Facts
    • 17.6.2. Business Overview
    • 17.6.3. Business Strategy
    • 17.6.4. Recent Developments
    • 17.6.5. SWOT Analysis
    • 17.6.6. Strengths
    • 17.6.7. Weaknesses
    • 17.6.8. Opportunities
    • 17.6.9. Threats
  • 17.7. Novartis Animal Health
    • 17.7.1. Key Facts
    • 17.7.2. Business Overview
    • 17.7.3. Product Segmentation
    • 17.7.4. Geographical Segmentation
    • 17.7.5. Business Strategy
    • 17.7.6. Recent Developments
    • 17.7.7. SWOT Analysis
    • 17.7.8. Strengths
    • 17.7.9. Weaknesses
    • 17.7.10. Opportunities
    • 17.7.11. Threats
  • 17.8. Sanofi
    • 17.8.1. Key Facts
    • 17.8.2. Business Overview
    • 17.8.3. Business Segmentation by Revenue 2013
    • 17.8.4. Business Segmentation by Revenue 2012 and 2013
    • 17.8.5. Geographical Segmentation by Revenue 2013
    • 17.8.6. Business Strategy
    • 17.8.7. Key Developments
    • 17.8.8. SWOT Analysis
    • 17.8.9. Strengths
    • 17.8.10. Weakness
    • 17.8.11. Opportunities
    • 17.8.12. Threats
  • 17.9. Zoetis
    • 17.9.1. Key Facts
    • 17.9.2. Business Overview
    • 17.9.3. Business Segmentation by Revenue 2013
    • 17.9.4. Business Segmentation by Revenue 2012 and 2013
    • 17.9.5. Geographical Segmentation by Revenue 2013
    • 17.9.6. Business Strategy
    • 17.9.7. Recent Developments
    • 17.9.8. SWOT Analysis
    • 17.9.9. Strengths
    • 17.9.10. Weaknesses
    • 17.9.11. Opportunities
    • 17.9.12. Threats

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Animal Vaccines Market 2013-2018 (US$ billion)
  • Exhibit 3: Global Animal Vaccines Market Segmentation by Product
  • Exhibit 4: Global Animal Vaccines Market by Market Segmentation 2013
  • Exhibit 5: Global Livestock Vaccines Market 2013-2018 (US$ billion)
  • Exhibit 6: Global Companion Animal Vaccines Market 2013-2018 (US$ billion)
  • Exhibit 7: Global Porcine Vaccines Market 2013-2018 (US$ billion)
  • Exhibit 8: Global Poultry Vaccines Market 2013-2018 (US$ billion)
  • Exhibit 9: Global Equine Vaccines Market 2013-2018 (US$ billion)
  • Exhibit 10: Global Other Animals Vaccines Market 2013-2018 (US$ billion)
  • Exhibit 11: Global Animal Vaccines Market 2013-2018 (in revenue)
  • Exhibit 12: Global Animal Vaccines Market 2013-2018 (in percent)
  • Exhibit 13: Global Animals Vaccines Market Segmentation by Technology
  • Exhibit 14: Global Animal Vaccines Market by Geographical Segmentation 2013
  • Exhibit 15: Animal Vaccines Market in Americas 2013-2018 (US$ billion)
  • Exhibit 16: Animal Vaccines Market in the EMEA Region
  • Exhibit 17: Animal Vaccines Market in the APAC Region
  • Exhibit 18: Global Animal Vaccine Market by Geographical Segmentation 2013-2018 (in percent)
  • Exhibit 19: Zoetis Revenue Segmentation by Geography
  • Exhibit 20: Zoetis Market Revenue by Species
  • Exhibit 21: Merck Animal Health by Revenue Segments
  • Exhibit 22: Sanofi by Revenue Segments
  • Exhibit 23: Bayer Healthcare: Business Segmentation by Revenue 2013
  • Exhibit 24: Bayer Healthcare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 25: Bayer Healthcare: Geographical Segmentation by Revenue 2013
  • Exhibit 26: Novartis Animal Health: Product Segmentation
  • Exhibit 27: Novartis Animal Health: Geographical Segmentation
  • Exhibit 28: Sanofi: Business Segmentation by Revenue 2013
  • Exhibit 29: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 30: Sanofi: Geographical Segmentation by Revenue 2013
  • Exhibit 31: Zoetis: Business Segmentation by Revenue 2013
  • Exhibit 32: Zoetis: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 33: Zoetis: Geographical Segmentation by Revenue 2013
Back to Top